Antithrombotic Therapy and Bleeding Risk Among Young Adults After Ischemic Stroke.

Rasing A, Verburgt E, Ekker MS, Schellekens MMI, Immens MHM, Verhoeven JI, Boot EM, van Alebeek ME, Brouwers PJAM, Arntz RM, van Dijk GW, van Uden IWM, Gons RAR, den Heijer T, van Tuijl JH, de Laat KF, van Norden AGW, Vermeer SE, van Zagten MSG, van Oostenbrugge RJ, Wermer MJH, Nederkoorn PJ, Kerkhoff H, Rooyer FA, van Rooij FG, van den Wijngaard IR, Ten Cate TJF, Tuladhar AM, Richard E, de Leeuw FE, Hilkens NA

Open source

DOI
10.1001/jamanetworkopen.2026.35826
Published
2026 Sep 1
Container
JAMA network open
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.35826,
  title = {Antithrombotic Therapy and Bleeding Risk Among Young Adults After Ischemic Stroke.},
  author = {Rasing A and Verburgt E and Ekker MS and Schellekens MMI and Immens MHM and Verhoeven JI and Boot EM and van Alebeek ME and Brouwers PJAM and Arntz RM and van Dijk GW and van Uden IWM and Gons RAR and den Heijer T and van Tuijl JH and de Laat KF and van Norden AGW and Vermeer SE and van Zagten MSG and van Oostenbrugge RJ and Wermer MJH and Nederkoorn PJ and Kerkhoff H and Rooyer FA and van Rooij FG and van den Wijngaard IR and Ten Cate TJF and Tuladhar AM and Richard E and de Leeuw FE and Hilkens NA},
  year = {2026},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2026.35826},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.35826}
}

RIS

TY  - JOUR
TI  - Antithrombotic Therapy and Bleeding Risk Among Young Adults After Ischemic Stroke.
AU  - Rasing A
AU  - Verburgt E
AU  - Ekker MS
AU  - Schellekens MMI
AU  - Immens MHM
AU  - Verhoeven JI
AU  - Boot EM
AU  - van Alebeek ME
AU  - Brouwers PJAM
AU  - Arntz RM
AU  - van Dijk GW
AU  - van Uden IWM
AU  - Gons RAR
AU  - den Heijer T
AU  - van Tuijl JH
AU  - de Laat KF
AU  - van Norden AGW
AU  - Vermeer SE
AU  - van Zagten MSG
AU  - van Oostenbrugge RJ
AU  - Wermer MJH
AU  - Nederkoorn PJ
AU  - Kerkhoff H
AU  - Rooyer FA
AU  - van Rooij FG
AU  - van den Wijngaard IR
AU  - Ten Cate TJF
AU  - Tuladhar AM
AU  - Richard E
AU  - de Leeuw FE
AU  - Hilkens NA
PY  - 2026
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.35826
UR  - https://doi.org/10.1001/jamanetworkopen.2026.35826
ER  - 

APA

A, R., E, V., MS, E., MMI, S., MHM, I., JI, V., EM, B., ME, V. A., PJAM, B., RM, A., GW, V. D., IWM, V. U., RAR, G., T, D. H., JH, V. T., KF, D. L., AGW, V. N., SE, V., MSG, V. Z., RJ, V. O., MJH, W., PJ, N., H, K., FA, R., FG, V. R., IR, V. D. W., TJF, T. C., AM, T., E, R., FE, D. L., & NA, H. (2026). Antithrombotic Therapy and Bleeding Risk Among Young Adults After Ischemic Stroke.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2026.35826

Source records